Finally, recent studies have paid more attention to individuals at high risk for AD, such as amnestic mild cognitive impairments [44, 45] and ApoE-4 allele carriers [46] as well as subjective cognitive decline [47]. This evidence concerns the gene APOE and Alzheimer disease.